Studies in vitro have suggested that a species barrier exists in functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecules. However, whether mouse CD4 + T cells restricted by HLA class II molecules are generated in HLA class II transgenic mice and respond to peptide antigens across this barrier has remained unclear. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to influenza hemagglutinin-derived peptide 30%319 (HA 307) and Streptococcus pyogenes M12 protein-derived peptide 347-397 (M6C2), respectively. Inhibition studies with several monoclonal antibodies showed that transgenic HLA class II molecules presented these peptides to mouse CD4 + T cells. Furthermore, T cell lines specific for HA 307 or M6C2 obtained from the transgenic mice could respond to the peptide in the context of relevant HLA class II molecules expressed on mouse L cell transfectants that lack the expression of mouse MHC class II. These findings indicate that interaction between HLA class II and mouse CD4 molecules is sufficient for provoking peptide-specific HLA class II-restricted T cell responses in HLA class II transgenic mice.
Summary
Studies in vitro have suggested that a species barrier exists in functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecules. However, whether mouse CD4 + T cells restricted by HLA class II molecules are generated in HLA class II transgenic mice and respond to peptide antigens across this barrier has remained unclear. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to influenza hemagglutinin-derived peptide 30%319 (HA 307) and Streptococcus pyogenes M12 protein-derived peptide 347-397 (M6C2), respectively. Inhibition studies with several monoclonal antibodies showed that transgenic HLA class II molecules presented these peptides to mouse CD4 + T cells. Furthermore, T cell lines specific for HA 307 or M6C2 obtained from the transgenic mice could respond to the peptide in the context of relevant HLA class II molecules expressed on mouse L cell transfectants that lack the expression of mouse MHC class II. These findings indicate that interaction between HLA class II and mouse CD4 molecules is sufficient for provoking peptide-specific HLA class II-restricted T cell responses in HLA class II transgenic mice.
I
nteraction of the CD4 coreceptor with class II products . of the MHC has a critical role in intrathymic selection (1, 2) and peripheral immune response to foreign antigens of CD4 + T cells (3) . The CD4 molecule binds to the 82 domain of the MHC class II molecule (4, 5) and provokes T cell responses by increasing avidity of T cell-APC interaction and/or by transmitting an intraceUular activation signal (6, 7) . Although human (HLA) and mouse (H-2) MHC have evolved from common ancestral genes (8) , several studies suggest that a species barrier exists in functional interaction between mouse CD4 and human class II molecules in vitro (9-11). Lamarre et al. (9) considered the possibility that mouse CD4 probably did not interact with the HLA-DP molecule by analyzing the response of CD4-CD8-T cell hybridoma. Vignali et al. (10) showed that the responses of mouse CD4 § T cells to peptide antigens were reduced by replacing the 82 domain of the I-A molecule on APC with that of the DR molecule. Furthermore, T cells from human CD4 transgenic mice have been shown to respond to human class II molecules in a xenogeneic MLR stronger than that from normal mice (11) . However, it has remained unclear whether mouse CD4 § T cells restricted by human class II molecules are generated in HLA class II transgenic mice and respond to foreign peptide antigen across this barrier. It is, therefore, essential to clarify this issue if we want to employ the HLA class II transgenic mice for investigating the role of HLA class II in regulating immune response and disease susceptibility.
We generated transgenic C57BL/6 (B6) mice carrying genes for both HLA-DQ6A (DQAI*0103) and -DQ6B (DQBI*0601) encoding ol and 8 chains of the HLA-DQ6 molecule, respectively (DQ6-B6) (12) , that for HLA-DRA (DRA*0101) encoding the monomorphic a chain of the HLA-DR molecule (DRA-B6) (13) , and that for HLA-DR51B (DRBS*0102) encoding the 8 chain of HLA-DR51 molecule (DR51B-B6). Here we show that DQ6-B6 and DR51-B6 obtained by crossing DR51B-B6 with DRA-B6 acquired peptide-specific, HLA-restricted T cell responses, and that functional interaction between HLA class II and mouse CD4 molecules was involved in these responses. Oslo, Norway) and anti-LA b mAb (Meiji, Odawara, Japan) as follows. Magnetic beads were added to the cell suspension and the preparation was centrifuged for 10 min at 1,500 rpm followed by resuspension of the cells and removal of the beads/IgG positive B cells. This step was repeated twice and cell suspensions were subsequently incubated with anti-LA b mAb at a saturating concentration for 30 min at 4~ The cells were then washed three times with complete medium and further enriched to T cells using magnetic beads. The enriched T cells (4 x 10 s) were cultured in 0.2 ml of complete medium in triplicate in 96-well flat-bottom tissue culture plates, containing 8 x 10 s irradiated (3,000 rad) syngeneic spleen cells as APCs in the presence or absence of antigen peptide at 37~ in a humidified atmosphere of 5% CO2 for 48 h. 
Results and Discussion
We previously reported that HLA-DQ6 molecules were expressed in the thymus, lungs, lymph nodes, and spleen in a tissue-specific manner as was MHC class II in DQ6-B6 (12) . In DR51-B6 obtained by crossing DR51B-B6 with DRA-B6, the DR51B transgene was expressed in the thymus, spleen, and lung (Fig. 1 A) . This suggested that HLA-DR51 molecules were expressed on various immunocompetent cells such as thymic epithelial cells, B cells, macrophages, and dendritic cells in DR51-B6 because DRA-B6 expressed DRoe chain as DRoLE3 b molecule on these cells (13) . Cell surface expressions of DR51 molecules on these immunocompetent cells were confirmed by FCM analysis (Fig. 1 B) . It should be noted that DR51-B6 also expresses a xenogeneic mixed isotype molecule, DRo~E3 b, as in DRA-B6 (Fig. 2) . Expression of the DRc~A3 b molecule in DRo~ single transgenic mice was not demonstrated by immunoprecipitation (26) nor was the Ao~bDR51t5 molecule in DR51B-B6 demonstrated by FCM using anti-DR3 polyclonal antibody (data not shown). Thus, DR51-B6 apparently expresses three different MHC class II molecules, DR51, DRczE3b, ' and I-AL In DQ6-B6, mixed isotype molecules were not detected by immunoprecipitation (12) .
In a previous study (12) , it was shown that DQ6-B6 did not produce antibodies specific for the DQ6 molecule, and that loss of MLR against the DQ6 molecule was observed in DQ6-B6, suggesting that DQ6-B6 acquired a tolerance to HLA-DQ6 molecule at the B and T cell levels. To investigate whether DR51-B6 acquired a tolerance to the HLA-DR51 molecule, mice were immunized with the EBV-transformed human B cell line, TOK, which expresses HLA-DR51 molecules, and the production of antibodies specific for DR51 molecule was examined. As expected, DR51-B6 did not produce antibodies against DR51 molecule, whereas B6, DRA-B6, and DR51B-B6 produced the antibodies (data not shown). In addition, a primary MLR using DR51-B6 spleen cells as stimulator showed that the transgenic DR51 molecule could stimulate T cells from B6, DRA-B6, and DR51B-B6, but not DR51-B6 (data not shown). These findings indicate that DR51-B6 acquired a tolerance to transgene products as had DQ6-B6, suggesting that transgenic HLA class II molecules contributed to eliminate self-reactive T cells as had MHC class II molecules.
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Next, in order to examine whether HLA class II molecules expressed in mice would provoke T cell responses to foreign peptide antigens, mice were immunized with influenza A hemagglutinin-derived peptide 307-319 (HA 307), known to be a satisfactory DR binding peptide (27) , or with Streptococcuspyogenes M12 protein-derived peptide 347-367 (M6C2), which is a DQ6-restricted antigenic peptide in humans (28) , and secondary proliferative T cell responses in vitro were measured. Fig. 3 A shows that DR51-B6 acquired the T cell response to HA 307, whereas no proliferative response was observed in B6, DRA-B6, or DR51B-B6. On the other hand, the immune response to M6C2 was observed only in DQ6-B6 (Fig. 3 B) . DR51-B6 and DQ6-B6 did not acquire the T cell response to M6C2 and HA 307, respectively (data not shown). Anti~ but not anti-CD8 mAb inhibited these responses (Fig. 3, C and D) . These results suggest that the DR51 molecule, but not DRotE3 b or I-A b, presented HA 307 to mouse CD4 + T cells in DR51-B6, whereas the DQ6 molecule presented M6C2 to CD4 § T cells in DQ6-B6. However, it remained to be determined whether functional interaction of mouse CD4 with HLA class II molecules was involved in these responses, because mouse CD4 might interact with the/3 chain of DRc~E3 b and/or I-A b expressed in addition to DR51 or DQ6 molecules on the same APC (9, 12) .
To clarify this point, inhibitory effects by several mAbs specific for mouse MHC class II molecules on the T cell responses were examined. As shown in Fig. 4 , mAbs specific for E3 b (17-3-3), which are known to react with DRotE3 b (13, 29) or those for A3 b (17/227), failed to block the responses as well as had anti-Act b (3JP). By contrast, the response was completely inhibited by anti-DR (L243) in DR51-B6 and anti-DQ (HUll) in DQ6-B6. These results suggest that the DRotE3 b or I-A b molecules did not play a major role in these responses.
To examine more closely the interaction of mouse CD4 with HLA class II, CD4 + T cell lines specific for HA 307 or M6C2 were obtained from DR51-B6 or DQ6-B6, respectively, and their restriction elements were investigated using mouse L cells transfected with various HLA class II as APCs that do not express endogenous mouse MHC class II molecules. Consistent with the blocking experiments, each T cell line specific for either HA 307 or M6C2 responded to the peptide antigen in the context of the relevant HLA class II molecules in the absence of mouse class II (Fig. 5, A and  B) . These responses were restricted to DR51 or DQ6 molecules because the L cells expressing each of the DR1, DR2, or DR4 molecules, which are known to present HA 307 to human T cells (27) , and those expressing DQ4, which binds M6C2 (data not shown), could not present the antigen peptides to these T cell lines. Spleen cells from bone marrow chimera-B6 and -DRA-B6, which were reconstituted with DR51-B6 BM, could stimulate the HA 307-specific DR51-restricted T cell line, but these bone marrow chimera mice did not acquire the T cell response to HA 307 (data not shown). These observations indicate that the responding T cells observed in the DK51-B6 express TCR antigens that were selected positively in the thymus by the transgene product, but not by I-A b or DR(xEB b molecules. Previous study (2) has shown that interaction of CD4 with MHC class II molecules is critical for the generation of MHC class II-restricted mature T cells by analyzing T cell differentiation in CD4-deficient mice. Taken together, we conclude that HLA class II-restricted mouse CD4 + T cells were generated by significant interac-tion between HLA class II and mouse CD4 molecules in the thymus of the transgenic mice, and that these cells could recognize antigen peptides in the context of HLA class II molecules.
Our results would contradict the previous observations showing that a species barrier exists in functional interaction between HLA class II and mouse CD4 molecules (9-11). However, it has been also suggested that this barrier is partial and that CD4 can bind to the MHC class II (x chain or a conserved site that itself is not species specific (10, 30) . We cannot assess in this study whether T cell responses in the HLA class II transgenic mice will be augmented by introducing human CD4, or whether a HLA class II transgenic mouse expressing chimeric human/mouse MHC class II molecules that contain mouse class II-CD4 interacting region will acquire stronger T cell response than the transgenic mice used in this study. However, one prominent feature of this study was that we established two strains of HLA class II transgenic mice expressing HLA-DR or -DQ molecules in a tissue-specific manner as MHC class II and T cell responses to peptide antigens were analyzed in an in vivo system. Therefore, our observations indicate that interaction between HLA class II and mouse CD4 molecules is physiologically sufficient for generating HLA class II-restricted mouse T cell repertoire and for provoking peptide-specific mouse T cell responses. Thus, we propose that HLA class II transgenic mice can serve to investigate the role of HLA class II molecules in regulating immune responses and disease susceptibility in humans.
